Online Inquiry

DSPE-PEG-COOH sodium salt

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Functionalized PEG Lipids
Catalog NO. BPG-2972
Product Name DSPE-PEG-COOH sodium salt
CAS 1403744-37-5
Molecular Formula (C2H4O)nC45H86NO12P.Na
Molecular Weight 2780.38
DSPE-PEG-COOH sodium salt
  • Scheme Design
  • Custom Synthesis
  • cGMP Manufacturing
  • Quality Assurance
  • Product Information
  • References
  • Documents
  • Reviews

Product Information

Description DSPE-PEG-COOH is DSPE-PEG with a carboxylic acid. It can be used for PEG-biochemical conjugation, and be utilized in micelles, liposomes, and other lipid-based drug carriers.
Synonyms Poly(oxy-1,2-ethanediyl), α-(carboxymethyl)-ω-[[(10R)-7-hydroxy-7-oxido-2,13-dioxo-10-[(1-oxooctadecyl)oxy]-6,8,12-trioxa-3-aza-7-phosphatriacont-1-yl]oxy]-, sodium salt (1:1)
Purity 95%
Solubility Soluble in warm aqeous solution as well as most organic solvents.
Appearance Powder
Shelf Life 1 Year.
Storage Store at -20°C
Exact Mass 2778.7
Hygroscopic Yes
Light Sensitive No
Percent Composition C 56.59%, H 9.32%, N 0.50%, Na 0.83%, O 31.65%, P 1.11%
References 1. Mashreghi M, Zamani P, Moosavian SA, Jaafari MR. Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma. Nanoscale Res Lett. 2020 May 7;15(1):101. doi: 10.1186/s11671-020-03334-9. PMID: 32383027; PMCID: PMC7206479. PubMed ID: 32383027.
2. Kong L, Li XT, Ni YN, Xiao HH, Yao YJ, Wang YY, Ju RJ, Li HY, Liu JJ, Fu M, Wu YT, Yang JX, Cheng L. Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer's Disease-Related Pathology in APP/PS-1 Mice. Int J Nanomedicine. 2020 Apr 23;15:2841-2858. doi: 10.2147/IJN.S239608. PMID: 32425521; PMCID: PMC7186891. PubMed ID: 32425521.
3. An J, Forchheimer D, Sävmarker J, Brülls M, Frenning G. Nanoscale characterization of PEGylated phospholipid coatings formed by spray drying on silica microparticles. J Colloid Interface Sci. 2020 May 21;577:92-100. doi: 10.1016/j.jcis.2020.05.045. Epub ahead of print. PMID: 32473480. PubMed ID: 32473480.
4. Kuo YC, Lou YI, Rajesh R. Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons. J Drug Target. 2020 May 12:1-12. doi: 10.1080/1061186X.2020.1761819. Epub ahead of print. PMID: 32338078. PubMed ID: 32338078.
5. Benne N, Martins Cardoso R, Boyle AL, Kros A, Jiskoot W, Kuiper J, Bouwstra J, Van Eck M, Slütter B. Complement Receptor Targeted Liposomes Encapsulating the Liver X Receptor Agonist GW3965 Accumulate in and Stabilize Atherosclerotic Plaques. Adv Healthc Mater. 2020 May;9(10):e2000043. doi: 10.1002/adhm.202000043. Epub 2020 Apr 24. PMID: 32329226. PubMed ID: 32329226.
6. Wei Y, Liu S, Pan C, Yang Z, Liu Y, Yong J, Quan L. Molecular Antenna-Sensitized Upconversion Nanoparticle for Temperature Monitored Precision Photothermal Therapy. Int J Nanomedicine. 2020 Mar 2;15:1409-1420. doi: 10.2147/IJN.S236371. PMID: 32184595; PMCID: PMC7060035. PubMed ID: 32184595.
7. Lee SWL, Campisi M, Osaki T, Possenti L, Mattu C, Adriani G, Kamm RD, Chiono V. Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier Microvasculature. Adv Healthc Mater. 2020 Apr;9(7):e1901486. doi: 10.1002/adhm.201901486. Epub 2020 Mar 3. PMID: 32125776. PubMed ID: 32125776.
8. Ye S , Liu Y , Lu Y , Ji Y , Mei L , Yang M , Gong X , Gu Q , Li D , Yang F , Li CJ . Cyclic RGD functionalized liposomes targeted to activated platelets for thrombosis dual-mode magnetic resonance imaging. J Mater Chem B. 2020 Jan 22;8(3):447-453. doi: 10.1039/c9tb01834d. PMID: 31833530. PubMed ID: 31833530.
9. Ramesh A , Kumar S , Nguyen A , Brouillard A , Kulkarni A . Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy. Nanoscale. 2020 Jan 23;12(3):1875-1885. doi: 10.1039/c9nr08670f. PMID: 31903467. PubMed ID: 31903467.
10. Yang F, Medik Y, Li L, Tian X, Fu D, Brouwer KLR, Wagner K, Sun B, Sendi H, Mi Y, Wang AZ. Nanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo. Small. 2020 Jan 23:e1906360. doi: 10.1002/smll.201906360. Epub ahead of print. PMID: 31972070. PubMed ID: 31972070.

Reviews

If you have any suggestions or comments about mPEG-Br, please submit a review immediately.

submit

Related Link

Why BOC Sciences?

  • Large Stock

    More than 2000+ products in inventory

  • Global Delivery

    Warehouses in multiple cities to ensure fast delivery

  • mg to kg

    Multi specification for academic research and industrial production

  • 24/7 Technical Support

    Strict process parameter control to ensure product quality

Products

Resources

Our Feature

BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

  • Our Feature icon1
  • Our Feature icon2
  • Our Feature icon3
  • Our Feature icon4
PEGylation of Peptides and Proteins

PEGylation of Peptides
and Proteins

Reduce the Immunogenicity of Peptide/Protein Drugs

Learn More

APPLICATIONS

APPLICATIONS

PEG linkers For Drug

Improved Circulation Half-Life

Learn More

Have Customer Reviewed On Us?

logo

Chat With Us

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.